Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific S Upside With Cardiology Devices Drives Momentum is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific makes second acquisition for $360M upfront
senior vice president and president of Interventional Cardiology Therapies at Boston Scientific, said in Monday’s announcement. Boston Scientific (NYSE: BSX), the third largest medical device ... Read More
Boston Scientific snags renal denervation developer SoniVie for $540M
Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ultrasound-based therapy for stubbornly high blood pressure. | The acquisition sets up the ... Read More
Boston Scientific to acquire SoniVie for $360M upfront payment
Boston Scientific (BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment. Read More
Boston Scientific to Buy Rest of SoniVie for Initial $360 Million
Boston Scientific has agreed to buy the rest of privately held medical-device company SoniVie for an initial $360 million in a deal that expands its portfolio of interventional cardiology therapies. Read More
Boston Scientific 4Q Profit Up on Strong Cardio Device Sales
Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device maker posted fourth ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus